The therapeutic effect of PEGlated nanoliposome of pistachio unsaturated oils and its efficacy to attenuate inflammation in multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial phase I

Journal of Neuroimmunology ◽

10.1016/j.jneuroim.2021.577768 ◽

2021 ◽

pp. 577768

Author(s):

Gholamhossein Hassanshahi ◽

Mojgan Noroozi Karimabad ◽

Ali Jebali

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Phase I ◽

Therapeutic Effect ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Trial Phase

Download Full-text

Evaluating the efficacy of memantine on improving cognitive functions in epileptic patients receiving anti-epileptic drugs: A double-blind placebo-controlled clinical trial (Phase IIIb pilot study)

Annals of Indian Academy of Neurology ◽

10.4103/0972-2327.179971 ◽

2016 ◽

Vol 19 (3) ◽

pp. 344 ◽

Cited By ~ 2

Author(s):

Priya Marimuthu ◽

Sathyanarayanan Varadarajan ◽

Muthuraj Krishnan ◽

Sundar Shanmugam ◽

Gireesh Kunjuraman ◽

...

Keyword(s):

Clinical Trial ◽

Pilot Study ◽

Cognitive Functions ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Epileptic Patients ◽

Phase Iiib ◽

Trial Phase

Download Full-text

Therapeutic Effect of Chang’an I Recipe (肠安 I 号方) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial

Chinese Journal of Integrative Medicine ◽

10.1007/s11655-016-2596-9 ◽

2016 ◽

Vol 24 (9) ◽

pp. 645-652 ◽

Cited By ~ 4

Author(s):

Xu-dong Tang ◽

Bin Lu ◽

Zhen-hua Li ◽

Wei Wei ◽

Li-na Meng ◽

...

Keyword(s):

Clinical Trial ◽

Irritable Bowel Syndrome ◽

Therapeutic Effect ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Irritable Bowel

Download Full-text

Zinc sulphate: A reasonable choice for depression management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial

Pharmacological Reports ◽

10.1016/j.pharep.2015.01.002 ◽

2015 ◽

Vol 67 (3) ◽

pp. 606-609 ◽

Cited By ~ 23

Author(s):

Soheila Salari ◽

Payam Khomand ◽

Modabber Arasteh ◽

Bahareh Yousefzamani ◽

Kambiz Hassanzadeh

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Zinc Sulphate ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Depression Management ◽

Reasonable Choice

Download Full-text

Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.

Journal of Neurology Neurosurgery & Psychiatry ◽

10.1136/jnnp.57.suppl.11 ◽

1994 ◽

Vol 57 (Suppl) ◽

pp. 11-14 ◽

Cited By ~ 19

Author(s):

J H Noseworthy ◽

P C O'Brien ◽

B G van Engelen ◽

M Rodriguez

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Intravenous Immunoglobulin ◽

Immunoglobulin Therapy ◽

Controlled Clinical Trial ◽

Theiler's Virus ◽

Double Blind ◽

Intravenous Immunoglobulin Therapy ◽

Double Blind Placebo ◽

Virus Model

Download Full-text

Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial

Clinical Nutrition ◽

10.1016/j.clnu.2015.05.003 ◽

2016 ◽

Vol 35 (3) ◽

pp. 592-599 ◽

Cited By ~ 105

Author(s):

I-Ju Chen ◽

Chia-Yu Liu ◽

Jung-Peng Chiu ◽

Chung-Hua Hsu

Keyword(s):

Clinical Trial ◽

Therapeutic Effect ◽

Green Tea ◽

Weight Reduction ◽

Green Tea Extract ◽

Controlled Clinical Trial ◽

High Dose ◽

Double Blind ◽

Double Blind Placebo ◽

Tea Extract

Download Full-text

Effects of 4-aminopyridine on attention and executive functions of patients with multiple sclerosis: Randomized, double-blind, placebo-controlled clinical trial. Preliminary report.

Multiple Sclerosis and Related Disorders ◽

10.1016/j.msard.2018.12.026 ◽

2019 ◽

Vol 28 ◽

pp. 117-124 ◽

Cited By ~ 2

Author(s):

C. Arreola-Mora ◽

J. Silva-Pereyra ◽

T. Fernández ◽

M. Paredes-Cruz ◽

B. Bertado-Cortés ◽

...

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Executive Functions ◽

Preliminary Report ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatment

European Journal of Neurology ◽

10.1111/j.1468-1331.2006.01533.x ◽

2006 ◽

Vol 13 (8) ◽

pp. 887-895 ◽

Cited By ~ 91

Author(s):

K. G. Warren ◽

I. Catz ◽

L. Z. Ferenczi ◽

M. J. Krantz

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Disease Progression ◽

Synthetic Peptide ◽

Progressive Multiple Sclerosis ◽

Hla Class Ii ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Short-Term Effect of High-Dose Vitamin D on the Level of Interleukin 10 in Patients with Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

NeuroImmunoModulation ◽

10.1159/000439278 ◽

2015 ◽

Vol 22 (6) ◽

pp. 400-404 ◽

Cited By ~ 26

Author(s):

Fereshteh Ashtari ◽

Nafiseh Toghianifar ◽

Sayyed Hamid Zarkesh-Esfahani ◽

Marjan Mansourian

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Interleukin 10 ◽

Term Effect ◽

Controlled Clinical Trial ◽

High Dose ◽

Short Term ◽

Double Blind ◽

Double Blind Placebo ◽

High Dose Vitamin

Download Full-text

Effect of high dose vitamin D intake on interleukin-17 levels in multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial

Journal of Neuroimmunology ◽

10.1016/j.jneuroim.2015.05.022 ◽

2015 ◽

Vol 285 ◽

pp. 125-128 ◽

Cited By ~ 29

Author(s):

Nafiseh Toghianifar ◽

Fereshteh Ashtari ◽

Sayyed Hamid Zarkesh-Esfahani ◽

Marjan Mansourian

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Vitamin D ◽

Controlled Clinical Trial ◽

High Dose ◽

Interleukin 17 ◽

Double Blind ◽

Double Blind Placebo ◽

Vitamin D Intake ◽

High Dose Vitamin

Download Full-text

Faculty Opinions recommendation of Effect of high dose vitamin D intake on interleukin-17 levels in multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725665992.793521853 ◽

2016 ◽

Author(s):

Frank Lammert

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Vitamin D ◽

Controlled Clinical Trial ◽

High Dose ◽

Interleukin 17 ◽

Double Blind ◽

Double Blind Placebo ◽

Vitamin D Intake ◽

High Dose Vitamin

Download Full-text